Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating income | -$432K | -$1.55M | -$2.37M | -$2.50M | -$2.69M | -$138M | -$27.3M | -$45.1M | -$32.2M | -$18.1M |
| Net income | -$432K | -$1.33M | -$2.43M | -$2.44M | -$16.7M | -$130M | -$26.1M | -$50.3M | -$32.1M | -$17.5M |
| EPS (diluted) | $0.00 | -$0.01 | -$0.03 | -$0.98 | -$6.85 | -$14.82 | -$1.06 | -$15.47 | -$73.05 | -$12.12 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$154K | -$624K | -$621K | -$2.50M | -$1.63M | -$10.5M | -$19.0M | -$40.3M | -$27.9M | -$19.0M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | $37.2K | $4.51M | $18.6M | $19.5M | $23.8M | $17.5M |
| Total assets | $2.72M | $2.36M | $2.18M | $2.57M | $2.08M | $6.05M | $20.1M | $35.1M | $25.2M | $21.6M |
| Total liabilities | $803K | $1.21M | $2.06M | $443K | $23.6M | $996K | $16.4M | $19.8M | $9.70M | $2.55M |
| Long-term debt | — | — | — | — | $62.5K | — | — | — | — | — |
| Shareholders' equity | $1.92M | $1.16M | $111K | $2.13M | -$21.5M | $5.05M | $3.67M | $15.3M | $15.5M | $19.0M |
| Retained earnings | -$1.00M | -$2.34M | -$4.77M | -$7.26M | -$41.0M | -$225M | -$251M | -$301M | -$334M | -$352M |
| Shares (wtd avg diluted) | 87.2M | 91.9M | 98.5M | 2.54M | 4.93M | 12.4M | 24.7M | 3.25M | 452K | 1.48M |
Every figure is extracted from BIOVIE INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.